1. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and their therapeutic utility.
Metabolic and Viral Diseases Drug Discovery Research, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.
Brad R
BR
Henke
D000544:Alzheimer Disease / Q000188:drug therapy; D001161:Arteriosclerosis / Q000188:drug therapy; D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008024:Ligands; D009369:Neoplasms / Q000188:drug therapy; D047495:PPAR gamma / Q000378:metabolism*; D047492:Peroxisome Proliferator-Activated Receptors / Q000378:metabolism* / Q000627:therapeutic use; D017434:Protein Structure, Tertiary; D045162:Thiazolidinediones / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D008024:Ligands; D047495:PPAR gamma; D047492:Peroxisome Proliferator-Activated Receptors; D045162:Thiazolidinediones